Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Original Article

Volume 5, Number 1-2, April 2015, pages 163-171


A Six-Week Home Exercise Program Improves Endothelial Function and CD34+ Circulating Progenitor Cells in Patients With Pre-Diabetes

Figures

Figure 1.
Figure 1. Flow chart of the study of 11 subjects with pre-diabetes. Dashed line: no exercise; solid line: exercise. A to B and C to D, are intervention periods (exercise or no exercise as the case may be) each of 6 weeks with 4 weeks of wash-out (between C to D). Six subjects started in no exercise phase and crossed over to exercise phase and five subjects started in exercise phase and crossed over to no exercise phase with 4 weeks of was-out in between. A, B, C and D were the measurement points for all outcome measures.
Figure 2.
Figure 2. (a) Blood biochemistry and fasting lipid profile of subjects in the non-exercise phase (white bars) and post-exercise phase (black bars). *P < 0.05. (b) Blood biochemistry showing inflammatory markers, fasting insulin and fasting leptin of subjects in the non-exercise phase (white bars) and post-exercise phase (black bars). *P < 0.05.
Figure 3.
Figure 3. Brachial artery flow mediated dilatation in the non-dominant arm during the non- exercise (white bar) and post exercise (black bar) phase. **P = 0.0013.
Figure 4.
Figure 4. CD34+ cell number and CFU-Hill colony counts in the sedentary phase (white bars) and post exercise phase (black bars). **P < 0.005.
Figure 5.
Figure 5. Migration of CD34+ cells in response to (a) VEGF-A (50 ng/mL), P = 0.1841 and (b) SDF-1 alpha (10 ng/mL), P = 0.0206 before (white bars) and after (black bars) exercise. Migration assay using VEGF-A as a chemotactic factor did not reach statistical significance.
Figure 6.
Figure 6. CD34+ gene expression before (white bars) and after (black bars) exercise. *P < 0.05.

Tables

Table 1. Patient Characteristics (n = 11)
 
No exercise (mean ± SEM)Exercise (mean ± SEM)
Age54 ± 855 ± 8
BMI29.4 ± 5.029.3 ± 5.2
BMR6,520.0 ± 887.86,518.7 ± 885.2
Fat %36.4 ± 10.736.6 ± 10.9
Fat mass68.9 ± 28.168.2 ± 28.9
Fat free mass113.4 ± 19.6113.8 ± 19.6
HbA1C (%)5.9 ± 0.35.8 ± 0.2
SBP128.5 ± 10.4127.7 ± 10.6
DBP76.5 ± 6.975.8 ± 9.1

 

Table 2. Physical Activity (n = 11)
 
PhaseNo exercise (mean ± SEM)Exercise (mean ± SEM)P-value
Physical activity (min/day) measured via actigraph, cut points from Freedson et al [19]. MVPA: moderate to vigorous physical activity.
Sedentary520 ± 16496 ± 170.003
Light230 ± 14236 ± 130.19
Lifestyle78 ± 987 ± 90.06
Moderate22 ± 526 ± 50.22
Vigorous0.3 ± 0.20.3 ± 0.30.88
MVPA22 ± 527 ± 50.22
All activity330 ± 23350 ± 210.02